×
About 6,838 results

ALLMedicine™ Urticaria Center

Research & Reviews  1,677 results

Predictive features associated with chronic spontaneous urticaria recurrence.
https://doi.org/10.1111/1346-8138.16119
The Journal of Dermatology; Toubi E, Vadasz Z

Sep 15th, 2021 - When chronic spontaneous urticaria (CSU) is resolved, patients are often apprehensive about the likelihood of recurrence, and want to know if we can predict this using clinical or laboratory markers. This question is crucial because CSU is frequen...

Urticaria and angioedema associated with SARS-CoV-2 infection.
https://doi.org/10.1503/cmaj.211087
CMAJ : Canadian Medical Association Journal = Journal De ... Zipursky JS, Croitoru D

Sep 9th, 2021 - Urticaria and angioedema associated with SARS-CoV-2 infection.|2021|Zipursky JS,Croitoru D,|

Quality of life for children with allergic skin diseases.
https://doi.org/10.2174/1573396317666210901124211
Current Pediatric Reviews; Hon KL, Chu S et. al.

Sep 8th, 2021 - Allergic skin diseases are highly prevalent among children. Patients with allergic skin diseases experience sociopsychological and quality-of-life (QoL) burdens in excess of those in the general population. Children and their caregivers are especi...

Epicutaneous challenge with protease allergen requires its protease activity to recall ...
https://doi.org/10.1080/1547691X.2021.1968548
Journal of Immunotoxicology; Ogasawara A, Yuki T et. al.

Sep 7th, 2021 - Epicutaneous exposure to allergenic proteins is an important sensitization route for skin diseases like protein contact dermatitis, immunologic contact urticaria, and atopic dermatitis. Environmental allergen sources such as house dust mites conta...

see more →

Guidelines  4 results

Considerations on biologicals for patients with allergic disease in times of the COVID-...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300800
Allergy Vultaggio A, Agache I et. al.

Jun 6th, 2020 - The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pandemic re-shaped doctor-patient interaction and challenged capacities of healthcare systems. It created many issues around the optimal and safest way to treat complex pat...

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and ma...
https://doi.org/10.1111/all.13397
Allergy Zuberbier T, Aberer W et. al.

Jan 18th, 2018 - This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. I...

Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/...
https://doi.org/10.1111/all.12370
Allergy Zuberbier T, Aberer W et. al.

Jun 6th, 2014 - This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured con...

Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German ...
https://doi.org/10.1111/j.1524-4725.2010.01495.x
Dermatologic Surgery : Official Publication for American ... Rabe E, Pannier F

Jul 16th, 2010 - Sclerotherapy involves the injection of a sclerosing agent for the elimination of intracutaneous, subcutaneous, and transfascial varicose veins. To update guidelines for sclerotherapy of varicose veins. The guidelines for sclerotherapy of varicose...

see more →

Drugs  824 results see all →

Clinicaltrials.gov  4 results

Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines
https://clinicaltrials.gov/ct2/show/NCT05024058

Sep 5th, 2021 - There are currently no approved therapies for patients with CINDU who remain symptomatic despite treatment with H1-antihistamines. The purpose of this study is to establish efficacy and safety of ligelizumab (QGE031) over placebo in participants w...

Atopic Diseases & Human Papilloma Virus
https://clinicaltrials.gov/ct2/show/NCT04397081

May 26th, 2020 - Patients between the ages of 30-65 with allergic complaints (sneezing, itching,runy nose, respiratory distress) were diagnosed "atopic disease" (allergic asthma, allergic rhinitis, allergic conjunctivitis, chronic urticaria and atopic dermatitis) ...

Mineral Status Ininfants With Cow's Milk Protein Allergy
https://clinicaltrials.gov/ct2/show/NCT04327297

Mar 31st, 2020 - Introduction Food allergy is defined as an adverse health effect arising from a specific Immune response that occurs following ingestion of a given food . Cow's milk protein (CMP) is the leading cause of food allergy in infants and young children ...

Bilastine Updosing - Characterization of Underlying Mechanisms
https://clinicaltrials.gov/ct2/show/NCT01271075

May 31st, 2012 - This is a double-blind, triple cross-over, placebo-controlled study to assess the efficacy, mechanisms, and safety of treatment with the antihistamine bilastine in patients with cold contact urticaria (CCU). Efficacy is primarily assessed by a cha...

see more →

News  224 results

Considerations in SM: Hereditary Alpha Tryptasemia
https://www.onclive.com/view/considerations-in-sm-hereditary-alpha-tryptasemia

Aug 16th, 2021 - Dan DeAngelo, MD, PhD: Concerning this newer entity of hereditary alpha tryptasemia, or HAT, how does this play into your algorithm? Patricia Lugar, MD, MS: We have a few patients we follow in the clinic who meet the criteria for familial alpha...

Swedish Registry Study Finds Atopic Dermatitis Significantly Associated With Autoimmune Diseases
https://www.medscape.com/viewarticle/943589

Jan 5th, 2021 - A diagnosis of atopic dermatitis in individuals ages 15 years or older, compared with controls without atopic dermatitis, was nearly twice as likely to be associated with autoimmune disease, in a case control study derived from Swedish national he...

FDA Grants Naxitamab Priority Review for Relapsed/Refractory High-Risk Neuroblastoma
https://www.onclive.com/view/fda-grants-naxitamab-priority-review-for-relapsedrefractory-highrisk-neuroblastoma

Dec 4th, 2020 - The FDA has granted a priority review designation to a biologics license application (BLA) for the investigational, humanized monoclonal antibody naxitamab (Danyelza) for the treatment of patients with relapsed/refractory high-risk neuroblastoma.1...

Pressure Urticaria Can Mimic Physical Abuse
https://www.medscape.com/viewarticle/938263

Sep 30th, 2020 - NEW YORK (Reuters Health) - Pressure urticaria in an infant can be misdiagnosed as physical abuse, according to a case report. "While physicians and healthcare providers should be keen on screening for mistreatment, different presentations of skin...

Antihistamines May Help Calm COVID-19 Cytokine Storm
https://www.medscape.com/viewarticle/937178

Sep 11th, 2020 - NEW YORK (Reuters Health) - Dual histamine-receptor blockade with cetirizine and famotidine appears to reduce pulmonary symptoms and may have other benefits in patients with COVID-19, according to a new study. "We are excited about the global pote...

see more →

Patient Education  2 results see all →